Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.40 |
| ▸ | MAOA | P21397 | 3/20 | 0.40 |
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8791233 | 0.82 | SLC6A2 (0.39) | TAAR1NISCH | |
| SCHEMBL664142 | 0.81 | — | — | |
| SCHEMBL136235 | 0.79 | GABRA1 (0.35) | TAAR1MAOA | |
| SCHEMBL28848589 | 0.76 | LMNA (0.35) | TAAR1TRPA1MAOA | |
| SCHEMBL1051818 | 0.76 | PTGS1 (0.31) | TAAR1MAOA | |
| SCHEMBL10773725 | 0.76 | LMNA (0.35) | TAAR1TRPA1MAOA | |
| SCHEMBL2698337 | 0.76 | SLC6A2 (0.30) | TAAR1MAOA | |
| SCHEMBL6886439 | 0.76 | TRPA1 (0.35) | TAAR1ALDH1A1TRPA1MAOA | |
| SCHEMBL25309170 | 0.74 | TRPA1 (0.32) | TRPA1 | |
| SCHEMBL1071095 | 0.74 | TRPA1 (0.32) | TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115557879-B | Compound and organic electronic device comprising same | 株式会社LG化学 | 2024-02-20 | — | — | CN | claimed |
| CN-110121796-B | Organic electroluminescent element and novel compound | 出光兴产株式会社 | 2021-10-01 | — | — | CN | claimed |
| EP-2314558-B1 | BENZOFLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT COMPRISING SAME | IDEMITSU KOSAN CO (JP) | 2014-05-14 | — | — | EP | claimed |
| EP-0820312-A4 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | DU PONT MERCK PHARMA (US) | 1998-03-18 | — | — | EP | claimed |
| EP-0820312-A1 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-01-28 | — | — | EP | claimed |
| WO-1996031243-A1 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-10-10 | — | — | WO | claimed |
| US-11950498-B2 | Compound, material for organic electroluminescence element using same, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-04-02 | — | — | US | disclosed |
| CN-117624144-A | Multiple host materials, organic electroluminescent compounds, and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-115557879-B | Compound and organic electronic device comprising same | 株式会社LG化学 | 2024-02-20 | — | — | CN | disclosed |
| US-11895917-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2024-02-06 | — | — | US | disclosed |
| US-11839153-B2 | Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-12-05 | — | — | US | disclosed |
| CN-117143480-A | Active ray-curable ink, method for forming cured product, and light-storage plate | 柯尼卡美能达株式会社 | 2023-12-01 | — | — | CN | disclosed |
| CN-116947847-A | Multiple host materials, organic electroluminescent compounds, and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-1244174-C | Electrode and battery using same | NEC CORP (JP) | 2006-03-01 | — | — | CN | disclosed |
| EP-1602648-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-12-07 | — | — | EP | disclosed |
| EP-1582516-A1 | NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-10-05 | — | — | EP | disclosed |
| CN-1411084-A | Electrode and battery using same | NEC CORP (JP) | 2003-04-16 | — | — | CN | disclosed |
| EP-0820312-A4 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | DU PONT MERCK PHARMA (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0820312-A1 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996031243-A1 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11839153-B2 | Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device | RER1, RPS19, RPL19 | TAAR1 1075/4885ALDH1A1 950/4885AOC3 901/4885 |
| US-11950498-B2 | Compound, material for organic electroluminescence element using same, organic electroluminescence element, and electronic device | PIEZO1, LEF1, ETV6 | TAAR1 1246/4885ALDH1A1 517/4885AOC3 449/4885 |
| US-11895917-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | PPOX, EPCAM, STOM | TAAR1 4025/4885ALDH1A1 1724/4885AOC3 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.